companies

NAVIDEA BIOPHARMACEUTICALS INC, which is in the In Vitro & In Vivo Diagnostic Substances [2835] industry, SEC S-1 filing on February 14, 2022 had …

NAVIDEA BIOPHARMACEUTICALS INC, which is in the In Vitro & In Vivo Diagnostic Substances [2835] industry, SEC S-1 filing on May 13, 2021 had 11172 …